Emerging Adulthood Management in Inflammatory Bowel Disease：New Progress and Implications

doi:10.12114/j.issn.1007-9572.2021.00.426

Abstract

Abstract: Inflammatory bowel disease（IBD），which is characterized by chronic course，high recurrence rate and canceration rate，has become a chronic disease affecting people's health that cannot be ignored.IBD patients during emerging adulthood have to face the dual challenges of disease management and social adaptation，but the emerging adulthood management is still a weak link in the health management of IBD in China.This paper reviewed the new progress in emerging adulthood management in IBD at home and abroad，with detailed analysis of the difficulties，key elements and projects of emerging adulthood management，and recommendations proposed for current and future development of emerging adulthood management in IBD in China，providing a reference for improving the management level.

Key words: Inflammatory bowel diseases, Review, Inflammatory bowel disease, Emerging adulthood, Health management

摘要： 基金项目：教育部人文社会科学青年项目（19YJCZH147）；南京中医药大学护理学优势学科开放课题（2019YSHL010）
炎症性肠病具有病程长、复发率高、癌变率高等特点，已成为影响人们健康的、不容忽视的慢性病之一。成人初显期炎症性肠病患者需面临疾病管理和社会适应的双重挑战，但目前成人初显期管理仍是我国炎症性肠病患者健康管理的薄弱环节。本文主要总结了国内外炎症性肠病患者成人初显期管理的研究进展，分析了炎症性肠病患者成人初显期面临的困境、进行管理的核心要素及相关管理项目，并提出了我国炎症性肠病患者成人初显期管理策略和发展建议，以期为提升我国炎症性肠病患者成人初显期管理水平提供参考。

关键词: 炎性肠疾病, 综述, 炎症性肠病, 成人初显期, 健康管理

TU Wenjing,XU Guihua. Emerging Adulthood Management in Inflammatory Bowel Disease：New Progress and Implications　[J]. Chinese General Practice, 2021, 24(15): 1861-1866. DOI: 10.12114/j.issn.1007-9572.2021.00.426.
徒文静,徐桂华. 炎症性肠病患者成人初显期管理的研究进展及启示[J]. 中国全科医学, 2021, 24(15): 1861-1866. DOI: 10.12114/j.issn.1007-9572.2021.00.426.

References

［1］SORRENTINO D.The coming of age of inflammatory bowel diseases in Asia［J］．Inflamm Intest Dis，2017，2（2）：93-94．DOI：10.1159/000480731.
［2］WANG H，FADIA M，FEWINGS I，et al．Histological remission（Nancy index）is superior to endoscopic mucosal healing in predicting relapse free survival in patients with ulcerative colitis in clinical and endoscopic remission［J］．Pathology，2019，51（Suppl 1）：S67．DOI：10.1093/ecco-jcc/jjy222.102.
［3］MAK J W Y，SO J，TANG W，et al．Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients：a population-based cohort study［J］．Scand J Gastroenterol，2020，55（3）：279-286．DOI：10.1080/00365521.2020.1731760.
［4］BOTTEMA R W B，DE VRIES H，HOUWEN R H J，et al．Impact of paediatric versus adult care setting on health care utilization in adolescents with inflammatory bowel disease［J］．J Pediatr Gastroenterol Nutr，2019，69（3）：310-316．DOI：10.1097/MPG.0000000000002399.
［5］HERZOG D，FOURNIER N，BUEHR P，et al．Prevalence of intestinal complications in inflammatory bowel disease：a comparison between paediatric-onset and adult-onset patients［J］．Eur J Gastroenterol Hepatol，2017，29（8）：926-931．DOI：10.1097/MEG.0000000000000896.
［6］肖园，许春娣.儿童炎症性肠病规范诊治面临的挑战［J］．中华儿科杂志，2019，57（7）：497-500．DOI：10.3760/cma.j.issn.0578-1310.2019.07.001.
XIAO Y，XU C D.Challenges in the standardized diagnosis and treatment of pediatric inflammatory bowel disease［J］．Chinese Journal of Pediatrics，2019，57（7）：497-500．DOI：10.3760/cma.j.issn.0578-1310.2019.07.001.
［7］陈莹.儿童炎症性肠病肠外表现研究进展［J］．国际儿科学杂志，2020，47（4）：248-251．DOI：10.3760/cma.j.issn.1673-4408.2020.04.007.
CHEN Y.Progress of extraintestinal manifestations of inflammatory bowel disease in children［J］．International Journal of Pediatrics，2020，47（4）：248-251．DOI：10.3760/cma.j.issn.1673-4408.2020.04.007.
［8］ARNETT J J.Conceptions of the transition to adulthood among emerging adults in American ethnic groups［J］．New Dir Child Adolesc Dev，2003（100）：63-76．DOI：10.1002/cd.75.
［9］WOOD D，CRAPNELL T，LAU L，et al．Emerging adulthood as a critical stage in the life course［M/OL］//Handbook of Life Course Health Development，Cham（CH）：Springer，2018：123-143．DOI：10.1007/978-3-319-47143-3_7.
［10］SPAIC T，ROBINSON T，GOLDBLOOM E，et al．Closing the gap：results of the multicenter Canadian randomized controlled trial of structured transition in young adults with type 1 diabetes［J］．Diabetes Care，2019，42（6）：1018-1026．DOI：10.2337/dc18-2187.
［11］SEQUEIRA P A，PYATAK E A，WEIGENSBERG M J，et al．Let's Empower and Prepare（LEAP）：evaluation of a structured transition program for young adults with type 1 diabetes［J］．Diabetes Care，2015，38（8）：1412-1419．DOI：10.2337/dc14-2577.
［12］GRAY W N，HOLBROOK E，MORGAN P J，et al．Transition readiness skills acquisition in adolescents and young adults with inflammatory bowel disease：findings from integrating assessment into clinical practice［J］．Inflamm Bowel Dis，2015，21（5）：1125-1131．DOI：10.1097/MIB.0000000000000352.
［13］VAN GRONINGEN J，ZINIEL S，ARNOLD J，et al．When independent healthcare behaviors develop in adolescents with inflammatory bowel disease［J］．Inflamm Bowel Dis，2012，18（12）：2310-2314．DOI：10.1002/ibd.22937.
［14］FISHMAN L N，HOUTMAN D，VAN GRONINGEN J，et al．Medication knowledge：an initial step in self-management for youth with inflammatory bowel disease［J］．J Pediatr Gastroenterol Nutr，2011，53（6）：641-645．DOI：10.1097/MPG.0b013e3182285316.
［15］JEGANATHAN J，LEE C H，RAHME A，et al．Pediatric-to-adult transition and medication adherence in patients with inflammatory bowel disease［J］．Inflamm Bowel Dis，2017，23（7）：1065-1070．DOI：10.1097/MIB.0000000000001114.
［16］MARíN-JIMéNEZ I，OROZCO-BELTRáN D，TORO J，et al．P767 Non-adherence behaviours of patients with inflammatory bowel disease and other chronic conditions.Relationship with experience with healthcare and beliefs in medications［J］．J Crohns Colitis，2019，13（Suppl 1）：S505．DOI：10.1093/ecco-jcc/jjy222.891.
［17］GONZALEZ F，BUISSON A，OLYMPIE A，et al．Impact of inflammatory bowel disease on working life：a French nationwide survey［J］．J Crohns Colitis，2018，12（Suppl 1）：S509-510．DOI：10.1093/ecco-jcc/jjx180.914.
［18］ROHDE J A，WANG Y，CUTINO C M，et al．Impact of disease disclosure on stigma：an experimental investigation of college students' reactions to inflammatory bowel disease［J］．J Health Commun，2018，23（1）：91-97．DOI：10.1080/10810730.2017.1392653.
［19］孟桃李.炎症性肠病对患者婚恋、性生活、生育影响的质性研究［D］．杭州：浙江中医药大学，2017.
［20］BROOKS A J，ROWSE G，RYDER A，et al．Systematic review：psychological morbidity in young people with inflammatory bowel disease——risk factors and impacts［J］．Aliment Pharmacol Ther，2016，44（1）：3-15．DOI：10.1111/apt.13645.
［21］BROOKS A J，SMITH P J，COHEN R，et al．UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care［J］．Gut，2017，66（6）：988-1000．DOI：10.1136/gutjnl-2016-313000.
［22］SHAPIRO J M，EI-SERAG H B，GANDLE C，et al．Recommendations for successful transition of adolescents with inflammatory bowel disease［J］．Clin Gastroenterol Hepatol，2020，18（2）：276-289.e2．DOI：10.1016/j.cgh.2019.04.063.
［23］PHILPOTT J R，KUROWSKI J A.Challenges in transitional care in inflammatory bowel disease：a review of the current literature in transition readiness and outcomes［J］．Inflamm Bowel Dis，2019，25（1）：45-55．DOI：10.1093/ibd/izy207.
［24］SATTOE J N T，PEETERS M A C，HAITSMA J，et al．Value of an outpatient transition clinic for young people with inflammatory bowel disease：a mixed-methods evaluation［J］．BMJ Open，2020，10（1）：e033535．DOI：10.1136/bmjopen-2019-033535.
［25］REGUEIRO M，CLICK B，HOLDER D，et al．Constructing an inflammatory bowel disease patient-centered medical home［J］．Clin Gastroenterol Hepatol，2017，15（8）：1148-1153.e4．DOI：10.1016/j.cgh.2017.05.026.
［26］COLE R，ASHOK D，RAZACK A，et al．Evaluation of outcomes in adolescent inflammatory bowel disease patients following transfer from pediatric to adult health care services：case for transition［J］．J Adolesc Health，2015，57（2）：212-217．DOI：10.1016/j.jadohealth.2015.04.012.
［27］WOOD D L，SAWICKI G S，MILLER M D，et al．The Transition Readiness Assessment Questionnaire（TRAQ）：its factor structure，reliability，and validity［J］．Acad Pediatr，2014，14（4）：415-422．DOI：10.1016/j.acap.2014.03.008.
［28］GRAY W N，MADDUX M H.Current transition practices in pediatric IBD：findings from a national survey of pediatric providers［J］．Inflamm Bowel Dis，2016，22（2）：372-379．DOI：10.1097/MIB.0000000000000642.
［29］BOSSUYT P，POUILLON L，BONNAUD G，et al．E-health in inflammatory bowel diseases：more challenges than opportunities？［J］．Dig Liver Dis，2017，49（12）：1320-1326．DOI：10.1016/j.dld.2017.08.026.
［30］阮佳音，吴林晔，李芳，等．炎症性肠病病人自我管理软件的可用性评价［J］．护理研究，2017，31（11）：1329-1333．DOI：10.3969/j.issn.1009-6493.2017.11.013.
RUAN J Y，WU L Y，LI F，et al．Usability evaluation of self management software of patients with inflammatory bowel disease［J］．Chinese Nursing Research，2017，31（11）：1329-1333．DOI：10.3969/j.issn.1009-6493.2017.11.013.
［31］CARLSEN K，JAKOBSEN C，HOUEN G，et al．Self-managed eHealth disease monitoring in children and adolescents with inflammatory bowel disease：a randomized controlled trial［J］．Inflamm Bowel Dis，2017，23（3）：357-365．DOI：10.1097/MIB.0000000000001026.
［32］齐妍妍，王爱平.炎症性肠病患者心理社会适应问卷的研制及信度效度检验［J］．中国护理管理，2020，20（1）：44-48．DOI：10.3969/j.issn.1672-1756.2020.01.010.
QI Y Y，WANG A P.Development and psychometric evaluation of a psychosocial adaptation questionnaire for patients with inflammatory bowel disease［J］．Chinese Nursing Management，2020，20（1）：44-48．DOI：10.3969/j.issn.1672-1756.2020.01.010.
［33］袁芮.成人初显期的心理社会发展研究及对社会工作的启示——基于社会资本与能动性的实证分析［J］．华东理工大学学报（社会科学版），2018，33（2）：77-89．DOI：10.3969/j.issn.1008-7672.2018.02.010.
YUAN R.Psycho-social development of emerging adults and its implications for social work：an empirical analysis of social capital and personal agency［J］．Journal of East China University of Science and Technology（Social Science Edition），2018，33（2）：77-89．DOI：10.3969/j.issn.1008-7672.2018.02.010.
［34］罗丹，林征，卞秋桂，等．炎症性肠病病人感知病耻感与生活质量的相关性研究［J］．护理研究，2018，32（13）：2027-2031．DOI：10.12102/j.issn.1009-6493.2018.13.011.
LUO D，LIN Z，BIAN Q G，et al．Correlation research between perceived stigma and quality of life in patients with inflammatory bowel disease［J］．Chinese Nursing Research，2018，32（13）：2027-2031．DOI：10.12102/j.issn.1009-6493.2018.13.011.
［35］王丹艳，陈焰，周云仙.青少年炎症性肠病患者夏令营体验的质性研究［J］．解放军护理杂志，2019，36（10）：29-31．DOI：10.3969/j.issn.1008-9993.2019.10.008.
WANG D Y，CHEN Y，ZHOU Y X.The experiences of the summer camp for adolescents with inflammatory bowel disease：a qualitative study［J］．Nursing Journal of Chinese People's Liberation Army，2019，36（10）：29-31．DOI：10.3969/j.issn.1008-9993.2019.10.008.

[1]	FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063.
[2]	LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949.
[3]	YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao. Research and Application of Digital Health Technologies in Multimorbidity Management [J]. Chinese General Practice, 2026, 29(21): 2933-2937.
[4]	CHENG Yu, HAN Shiyao, SUN Ping, XIANG Juan, YANG Hui, LI Dongze, ZHENG Li, LIAO Xiaoyang. Analysis of Socioeconomic and Demographic Challenges in Chronic Disease Management [J]. Chinese General Practice, 2026, 29(20): 2800-2807.
[5]	LI Wanyu, JIN Hua, YANG Sen, FU Qiangqiang, YU Dehua. Assessment and Optimization of Community Health Behaviors Guided by the Behaviour Change Wheel Theory [J]. Chinese General Practice, 2026, 29(19): 2688-2694.
[6]	ZHAO Xinran, WU Yibo, ZHANG Xuxi, CHEN Ping, SUN Xinying. The Current Situation and Influencing Factors of Smart Health Management Services and Devices Utilization among Chinese Adults: a Mixed Methods Study [J]. Chinese General Practice, 2026, 29(19): 2724-2734.
[7]	CHEN Yiping, ZHANG Jianmei, LI Yanhu, LI Rui, ZHANG Ruiping, YANG Ping. Advances in the Diagnosis and Treatment of Post-COVID-19 Condition of Myocardial Injury [J]. Chinese General Practice, 2026, 29(18): 2585-2592.
[8]	ZHANG Mingyue, HOU Yan. Research Progress of Exhaled Nitric Oxide and Alveolar Nitric Oxide in Interstitial Lung Diseases [J]. Chinese General Practice, 2026, 29(18): 2571-2576.
[9]	MA Xiaoyu, MA Xiaomei, WU Guozhi, ZHENG Ya, GUO Qinghong. Research Progress of Neutrophil Extracellular Traps in Gastric Cancer [J]. Chinese General Practice, 2026, 29(17): 2425-2432.
[10]	FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258.
[11]	LI Jiawei, GE Aoqi, GAO Xinyi, LI Juanjuan, YUAN Beibei. The Concept, Connotation, and Pathways of the Integration of Medical Care and Preventive Services in China: a Systematic Review [J]. Chinese General Practice, 2026, 29(16): 2156-2166.
[12]	WANG Yang, JIN Hua, YANG Sen, YANG Hui, YU Dehua. Reconfiguring the Functional Features of Primary Care in a Non-gatekeeping Context: a 15-Year Mixed-methods Systematic Review from China [J]. Chinese General Practice, 2026, 29(16): 2140-2155.
[13]	WANG Ziwen, GAO Gangqiang, WANG Zhong, WU You. Consistency Evaluation of the Improved 2-minute Step Test and the 6-minute Walk Test in Community Populations [J]. Chinese General Practice, 2026, 29(16): 2214-2220.
[14]	ZOU Jian, LI Wanping, GE Handa, JIN Zhe, RUFEINA· Tuerxun, LI Juan, WEI Anhua, FENG Da. Study on Potentially Inappropriate Medication Use among the Community Elderly Patients in Hubei Province [J]. Chinese General Practice, 2026, 29(13): 1759-1765.
[15]	ZHANG Qiang, ZHAO Wenxia, WANG Ziyi, YAN Le, LIANG Haowei, WANG Jinfan, FANG Jinhua, LU Cuncun. Interpretation of the Reporting Guideline for Systematic Reviews of Outcome Measurement Instruments (PRISMA-COSMIN for OMIs 2024) [J]. Chinese General Practice, 2026, 29(13): 1766-1775.